Skip to main content
. 2012 Apr 4;7(4):e34493. doi: 10.1371/journal.pone.0034493

Figure 5. IgG, IgA, and IgM concentration.

Figure 5

IgG, IgA, and IgM concentration was analyzed at the indicated time points in the sera of the patient who developed PML (pmlMS; black bars) and patients treated with natalizumab (nMS; white bars). Bar height represents the mean value and error bars represent the 95% confidence interval of the mean. * Measures of the pmlMS patient that were outside the 95% confidence interval of the means found in nMS. Dashed lines represent the lowest limit of the laboratory reference interval for healthy subjects.